Epiglottitis

Vaccination with Haemophilus influenzae type B (Hib) conjugated vaccine has reduced the incidence by about 95% in the US.[16]Centers for Disease Control and Prevention. Haemophilus influenzae invasive disease among children aged less than 5 years - California, 1990-1996. MMWR Morb Mortal Wkly Rep. 1998 Sep 11;47(35):737-40. http://www.cdc.gov/mmwr/preview/mmwrhtml/00054672.htm http://www.ncbi.nlm.nih.gov/pubmed/9746431?tool=bestpractice.com ​ In the US, the childhood immunization schedule recommends administration of a conjugate Hib vaccine series beginning at age 2 months, with either a 2-dose or 3-dose series depending on the specific vaccine used, and a later booster dose at age 12 through 15 months.

In American Indian or Alaska Native infants, a population at increased risk of Hib disease, a hexavalent combination vaccine or a monovalent vaccine are the preferential recommendation.[19]Collins JP, Loehr J, Chen WH, et al. Use of Haemophilus influenzae type b-containing vaccines among American Indian and Alaska native infants: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Sep 12;73(36):799-802. https://pmc.ncbi.nlm.nih.gov/articles/PMC11392226 http://www.ncbi.nlm.nih.gov/pubmed/39264849?tool=bestpractice.com ​ For full details of US immunization schedules, including indications for booster doses and catch-up schedules, the Advisory Committee on Immunization Practices guidelines should be consulted:

• CDC: recommended child and adolescent immunization schedule for ages 18 years or younger, United States Opens in new window

• CDC: recommended adult immunization schedule for ages 19 years or older, United States Opens in new window

Vaccination with Hib conjugated vaccine if not previously done so.